AKT1 and neoplasm: In melanoma, tumor cells exchange miR-222 via exosomes to enhance tumor malignancy by the activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway, via the downregulation of its target gene p27Kip1 [348].